Literature DB >> 19248110

Early targets of nuclear RNP humoral autoimmunity in human systemic lupus erythematosus.

Brian D Poole1, Rebecca I Schneider, Joel M Guthridge, Cathy A Velte, Morris Reichlin, John B Harley, Judith A James.   

Abstract

OBJECTIVE: The U1 small nuclear RNPs are common targets of autoantibodies in lupus and other autoimmune diseases. However, the etiology and progression of autoimmune responses directed against these antigens are not well understood. The aim of this study was to use a unique collection of serial samples obtained from patients before and after the development of nuclear RNP (nRNP) antibodies to investigate early humoral events in the development of anti-nRNP autoimmunity.
METHODS: Lupus patients with sera available from both before and after the development of nRNP antibody precipitin were identified from the Oklahoma Clinical Immunology Serum Repository. Antibodies in the serial samples were analyzed by enzyme-linked immunosorbent assay, Western blotting, solid-phase epitope mapping, and competition assays.
RESULTS: The first-detected nRNP antibodies targeted 6 common initial epitopes in nRNP A, 2 in nRNP C, and 9 in nRNP 70K. The initial epitopes of nRNP A and nRNP C were significantly enriched for proline and shared up to 95% sequence homology. The initial nRNP 70K humoral epitopes differed from those of nRNP A and nRNP C. The initial antibodies to nRNP A and nRNP C were cross-reactive with the SmB'-derived peptide PPPGMRPP. Antibody binding against all 3 nRNP subunits diversified significantly over time.
CONCLUSION: Autoantibodies to nRNP A and nRNP C initially targeted restricted, proline-rich motifs. Antibody binding subsequently spread to other epitopes. The similarity and cross-reactivity between the initial targets of nRNP and Sm autoantibodies identifies a likely commonality in cause and a focal point for intermolecular epitope spreading.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19248110      PMCID: PMC2653589          DOI: 10.1002/art.24306

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  49 in total

1.  A SmD peptide induces better antibody responses to other proteins within the small nuclear ribonucleoprotein complex than to SmD protein via intermolecular epitope spreading.

Authors:  Umesh S Deshmukh; Harini Bagavant; Davis Sim; Vyankatesh Pidiyar; Shu Man Fu
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

2.  Comparison of two different methods using overlapping synthetic peptides for localizing linear B cell epitopes in the U1 snRNP-C autoantigen.

Authors:  H Halimi; H Dumortier; J P Briand; S Muller
Journal:  J Immunol Methods       Date:  1996-11-29       Impact factor: 2.303

3.  Human lupus anti-spliceosome A protein autoantibodies bind contiguous surface structures and segregate into two sequential epitope binding patterns.

Authors:  J A James; J B Harley
Journal:  J Immunol       Date:  1996-05-15       Impact factor: 5.422

4.  Peptide autoantigenicity of the small nuclear ribonucleoprotein C.

Authors:  J A James; J B Harley
Journal:  Clin Exp Rheumatol       Date:  1995 May-Jun       Impact factor: 4.473

5.  Linear epitope mapping of an Sm B/B' polypeptide.

Authors:  J A James; J B Harley
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

6.  Interaction between the U1 snRNP-A protein and the 160-kD subunit of cleavage-polyadenylation specificity factor increases polyadenylation efficiency in vitro.

Authors:  C S Lutz; K G Murthy; N Schek; J P O'Connor; J L Manley; J C Alwine
Journal:  Genes Dev       Date:  1996-02-01       Impact factor: 11.361

7.  Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target.

Authors:  S Fatenejad; W Brooks; A Schwartz; J Craft
Journal:  J Immunol       Date:  1994-06-01       Impact factor: 5.422

8.  Basic amino acids predominate in the sequential autoantigenic determinants of the small nuclear 70K ribonucleoprotein.

Authors:  J A James; R H Scofield; J B Harley
Journal:  Scand J Immunol       Date:  1994-06       Impact factor: 3.487

9.  Prevalence and clinical significance of antibodies to ribonucleoproteins in systemic lupus erythematosus in Malaysia.

Authors:  C L Wang; L Ooi; F Wang
Journal:  Br J Rheumatol       Date:  1996-02

10.  Immunoglobulin epitope spreading and autoimmune disease after peptide immunization: Sm B/B'-derived PPPGMRPP and PPPGIRGP induce spliceosome autoimmunity.

Authors:  J A James; T Gross; R H Scofield; J B Harley
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  14 in total

Review 1.  The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease.

Authors:  Alina Dima; Ciprian Jurcut; Cristian Baicus
Journal:  Rheumatol Int       Date:  2018-05-23       Impact factor: 2.631

2.  Epitope mapping of the U1 small nuclear ribonucleoprotein particle in patients with systemic lupus erythematosus and mixed connective tissue disease.

Authors:  J A Somarelli; A Mesa; R Rodriguez; R Avellan; L Martinez; Y J Zang; E L Greidinger; R J Herrera
Journal:  Lupus       Date:  2011-03       Impact factor: 2.911

Review 3.  Implications of the parent-into-F1 model for human lupus pathogenesis: roles for cytotoxic T lymphocytes and viral pathogens.

Authors:  Charles S Via
Journal:  Curr Opin Rheumatol       Date:  2010-09       Impact factor: 5.006

Review 4.  The U1-snRNP complex: structural properties relating to autoimmune pathogenesis in rheumatic diseases.

Authors:  Nicole H Kattah; Michael G Kattah; Paul J Utz
Journal:  Immunol Rev       Date:  2010-01       Impact factor: 12.988

5.  RNA recognition motif (RRM) of La/SSB: the bridge for interparticle spreading of autoimmune response to U1-RNP.

Authors:  John G Routsias; Nikolaos Kyriakidis; Michael Latreille; Athanasios G Tzioufas
Journal:  Mol Med       Date:  2009-10-14       Impact factor: 6.354

6.  60 kD Ro and nRNP A frequently initiate human lupus autoimmunity.

Authors:  Latisha D Heinlen; Micah T McClain; Lauren L Ritterhouse; Benjamin F Bruner; Colin C Edgerton; Michael P Keith; Judith A James; John B Harley
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

7.  Mapping epitopes of U1-70K autoantibodies at single-amino acid resolution.

Authors:  David James Haddon; Justin Ansel Jarrell; Vivian K Diep; Hannah E Wand; Jordan V Price; Stephanie Tangsombatvisit; Grace M Credo; Sally Mackey; Cornelia L Dekker; Emily C Baechler; Chih Long Liu; Madoo Varma; Paul J Utz
Journal:  Autoimmunity       Date:  2015-08-31       Impact factor: 2.815

8.  Evaluating the diagnostic and prognostic value of lone anti-Sm for autoimmune diseases using Euroimmun line immunoassays.

Authors:  Yanming Meng; Shu Deng; Zhuochun Huang; Jing Hu; Junlong Zhang; Danjun Xu; Shuyun Qin; Chunyu Tan; Yongkang Wu
Journal:  Clin Rheumatol       Date:  2018-07-12       Impact factor: 2.980

9.  Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women.

Authors:  Jon J Ladd; Timothy Chao; Melissa M Johnson; Ji Qiu; Alice Chin; Rebecca Israel; Sharon J Pitteri; Jianning Mao; Mei Wu; Lynn M Amon; Martin McIntosh; Christopher Li; Ross Prentice; Nora Disis; Samir Hanash
Journal:  Cancer Res       Date:  2012-12-26       Impact factor: 12.701

10.  Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden.

Authors:  Catharina Eriksson; Heidi Kokkonen; Martin Johansson; Göran Hallmans; Göran Wadell; Solbritt Rantapää-Dahlqvist
Journal:  Arthritis Res Ther       Date:  2011-02-22       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.